Al-Ejeh, F; Pajic, M; et al. Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma. CLINICAL CANCER RESEARCH 20:3187-3197(2014).
Kuroda, S; Tam, J; et al. EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage. INTERNATIONAL JOURNAL OF NANOMEDICINE 9:3825-3839(2014).